Global trends and determinants of HRD and BRCA testing in ovarian cancer management: a cross-sectional study from the european network of young gynaecologic oncologists (ENYGO)

International Journal of Gynecological Cancer 2026

View at publisher
Authors: Tibor Andrea Zwimpfer, Houssein El Hajj, Esra Bilir, Matteo Lambertini, Rodrigo Sánchez-Bayona, Maria Kfoury, Joanna P. Kacperczyk-Bartnik, Martina Aida Ángeles, Andrea Rosati, Giuseppe Caruso, Khayal Gasimli, Zoia Razumova
+8 more İlker Kahramanoğlu, Nicolò Bizzarri, Aleksandra Natalia Strojna, Isabelle Laure Ray-Coquard, Frédéric C. Amant, Alejandra Martínez, Viola Heinzelmann-Schwarz, Stamatios Petousis
DOI: 10.1016/j.ijgc.2025.103006
Cited by: 0

Fields of Study & Subjects

BRCA gene mutations in cancer PARP inhibition in cancer therapy Ovarian cancer diagnosis and treatment

Publication details

Journal / source
International Journal of Gynecological Cancer
Volume
36
Issue
2
Pages
103006–103006
Publication date
1 February 2026
Language
EN